This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ARCK Arbor Rapha Capital Bioholdings Corp. I (ARCK) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Arbor Rapha Capital Bioholdings Corp. I Stock (NASDAQ:ARCK) 30 days 90 days 365 days Advanced Chart Get ARCK alerts:Sign Up Key Stats Today's Range$11.90▼$11.9050-Day Range$10.42▼$15.4152-Week Range$9.93▼$15.59VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector. The company was incorporated in 2021 and is based in Uniondale, New York. Read More Receive ARCK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arbor Rapha Capital Bioholdings Corp. I and its competitors with MarketBeat's FREE daily newsletter. Email Address ARCK Stock News HeadlinesDRGV Dragon Capital Group, Corp.October 19, 2024 | seekingalpha.comECN Capital Corp. (ECNCF)April 18, 2024 | finance.yahoo.comA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.July 14 at 2:00 AM | American Alternative (Ad)SuRo Capital Corp.February 22, 2024 | wsj.comReady Capital Corp.February 17, 2024 | wsj.comOxford Lane Capital Corp. (OXLC)February 5, 2024 | au.finance.yahoo.comDeal Pro Capital Corporation (DPCC-P.V)January 16, 2024 | ca.finance.yahoo.comQuad 7 CapitalNovember 21, 2023 | seekingalpha.comSee More Headlines ARCK Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Arbor Rapha Capital Bioholdings Corp. I own? Based on aggregate information from My MarketBeat watchlists, some other companies that Arbor Rapha Capital Bioholdings Corp. I investors own include Criteo (CRTO), AzurRx BioPharma (AZRX), Alnylam Pharmaceuticals (ALNY), Argos Therapeutics (ARGSQ), Editas Medicine (EDIT), abrdn Asia-Pacific Income Fund (FAX) and Weidai (WEI). Company Calendar Today7/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry UNCLASSIFIED Sub-IndustryN/A Current SymbolNASDAQ:ARCK CIK1452872 Webwww.arcgrpinc.com Phone516-506-4200FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:ARCK) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arbor Rapha Capital Bioholdings Corp. I Please log in to your account or sign up in order to add this asset to your watchlist. Share Arbor Rapha Capital Bioholdings Corp. I With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
